Influence of nitric oxide agents in the rat amygdala on anxiogenic-like effect induced by histamine

Neuroscience Letters

Volumn 489, Issue 1, 2011, Pages 38-42

  Zarrindast, Mohammad Reza ^a,b,c,d,e   Nasehi, Mohammad ^f   Khansari, Mohammad ^g   Bananej, Maryam ^g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Iranian Neuroscience Research Network   (Iran)

^d INSTITUTE FOR STUDIES IN THEORETICAL PHYSICS AND MATHEMATICS IPM   (Iran)

^e INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^f ISLAMIC AZAD UNIVERSITY   (Iran)

^g ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Anxiety; Elevated plus maze; Histamine; L arg; L NAME; Rat(s)

Indexed keywords

ARGININE; HISTAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR; CANNULA; CONTROLLED STUDY; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

AMYGDALA; ANIMALS; ANXIETY; ARGININE; BEHAVIOR, ANIMAL; ENZYME INHIBITORS; HISTAMINE; MALE; MAZE LEARNING; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 78650809665     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.11.062     Document Type: Article

References (34)

1. Almeida R.C., Felisbino C.S., Lopez M.G., Rodrigues A.L., Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav. Brain Res. 2006, 168:318-322.
2. Alvarez E.O., Banzan A.M. Histamine in dorsal and ventral hippocampus. II. Effects of H1 and H2 histamine antagonists on exploratory behavior in male rats. Physiol. Behav. 1986, 37:39-45.
3. Araki T., Mizutani H., Matsubara M., Imai Y., Mizugaki M., Itoyama Y. Nitric oxide synthase inhibitors cause motor deficits in mice. Eur. Neuropsychopharmacol. 2001, 11:125-133.
4. Bannerman D.M., Rawlins J.N., McHugh S.B., Deacon R.M., Yee B.K., Bast T., Zhang W.N., Pothuizen H.H., Feldon J. Regional dissociations within the hippocampus-memory and anxiety. Neurosci. Biobehav. Rev. 2004, 28:273-283.
5. Czech D.A., Jacobson E.B., LeSueur-Reed K.T., Kazel M.R. Putative anxiety-linked effects of the nitric oxide synthase inhibitor l-NAME in three murine exploratory behavior models. Pharmacol. Biochem. Behav. 2003, 75:741-748.
6. De Oliveira C.L., Del Bel E.A., Guimaraes F.S. Effects of l-NOARG on plus-maze performance in rats. Pharmacol. Biochem. Behav. 1997, 56:55-59.
7. Del Bel E.A., Guimaraes F.S., Bermudez-Echeverry M., Gomes M.Z., Schiaveto-de-souza A., Padovan-Neto F.E., Tumas V., Barion-Cavalcanti A.P., Lazzarini M., Nucci-da-Silva L.P., de Paula-Souza D. Role of nitric oxide on motor behavior. Cell Mol. Neurobiol. 2005, 25:371-392.
8. Forestiero D., Manfrim C.M., Guimaraes F.S., de Oliveira R.M. Anxiolytic-like effects induced by nitric oxide synthase inhibitors microinjected into the medial amygdala of rats. Psychopharmacology (Berlin) 2006, 184:166-172.
9. Guimaraes F.S., Beijamini V., Moreira F.A., Aguiar D.C., de Lucca A.C. Role of nitric oxide in brain regions related to defensive reactions. Neurosci. Biobehav. Rev. 2005, 29:1313-1322.
10. Hanbauer I., Wink D., Osawa Y., Edelman G.M., Gally J.A. Role of nitric oxide in NMDA-evoked release of [3H]-dopamine from striatal slices. Neuroreport 1992, 3:409-412.
11. Hellbom E. Chlorpheniramine, selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment. Med. Hypotheses 2006, 66:689-690.
12. Ito C, Shen H., Toyota H., Kubota Y., Sakurai E., Watanabe T., Sato M. Effects of the acute and chronic restraint stresses on the central histaminergic neuron system of Fischer rat. Neurosci. Lett. 1999, 262:143-145.
13. Kriegsfeld L.J., Eliasson M.J., Demas G.E., Blackshaw S., Dawson T.M., Nelson R.J., Snyder S.H. Nocturnal motor coordination deficits in neuronal nitric oxide synthase knock-out mice. Neuroscience 1999, 89:311-315.
14. Krukoff T.L., Khalili P. Stress-induced activation of nitric oxide-producing neurons in the rat brain. J. Comp. Neurol. 1997, 377:509-519.
15. Li S., Quock R.M. Comparison of N2O- and chlordiazepoxide-induced behaviors in the light/dark exploration test. Pharmacol. Biochem. Behav. 2001, 68:789-796.
16. Malmberg-Aiello P., Ipponi A., Bartolini A., Schunack W. Mouse light/dark box test reveals anxiogenic-like effects by activation of histamine H1 receptors. Pharmacol. Biochem. Behav. 2002, 71:313-318.
17. Moncada S. The l-arginine: nitric oxide pathway, cellular transduction and immunological roles. Adv. Second Messenger Phosphoprotein Res. 1993, 28:97-99.
18. Monzon M.E., Varas M.M., De Barioglio S.R. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 2001, 22:1043-1047.
19. Moreira F.A., Molchanov M.L., Guimaraes F.S. Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats. Psychopharmacology (Berlin) 2004, 171:199-203.
20. Orofino A.G., Ruarte M.B., Alvarez E.O. Exploratory behaviour after intra-accumbens histamine and/or histamine antagonists injection in the rat. Behav. Brain Res. 1999, 102:171-180.
21. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Academic Press, London, UK. 6th ed.
22. Philippu A., Prast H. Importance of histamine in modulatory processes, locomotion and memory. Behav. Brain Res. 2001, 124:151-159.
23. Privou C, Knoche A., Hasenohrl R.U., Huston J.P. The H1- and H2-histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 1998, 37:1019-1032.
24. Raber J., Koob G.F., Bloom F.E. Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J. Pharmacol. Exp. Ther. 1995, 272:815-824.
25. Roohbakhsh A., Moghaddam A.H., Massoudi R., Zarrindast M.R. Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin. Exp. Pharmacol. Physiol. 2007, 34:223-229.
26. Ruarte M.B., Orofino A.G., Alvarez E.O. Hippocampal histamine receptors and conflictive exploration in the rat: studies using the elevated asymmetric plus-maze. Braz. J. Med. Biol. Res. 1997, 30:1451-1461.
27. Shin I.C., Kim H.C., Swanson J., Hong J.T., Oh K.W. Anxiolytic effects of acute morphine can be modulated by nitric oxide systems. Pharmacology 2003, 68:183-189.
28. Steinbusch H.W., Sauren Y., Groenewegen H., Watanabe T., Mulder A.H. Histaminergic projections from the premammillary and posterior hypothalamic region to the caudate-putamen complex in the rat. Brain Res. 1986, 368:389-393.
29. Trabace L., Kendrick K.M. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation. J. Neurochem. 2000, 75:1664-1674.
30. Volke V., Soosaar A., Koks S., Bourin M., Mannisto P.T., Vasar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berlin) 1997, 131:399-405.
31. Volke V., Wegener G., Bourin M., Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav. Brain Res. 2003, 140:141-147.
32. Zarrindast M.R., Moghadam A.H., Rostami P., Roohbakhsh A. The effects of histaminergic agents in the central amygdala of rats in the elevated plus-maze test of anxiety. Behav. Pharmacol. 2005, 16:643-649.
33. Zarrindast M.R., Naghdi-Sedeh N., Nasehi M., Sahraei H., Bahrami F., Asadi F. The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response. Neurosci. Lett. 2010, 475:156-160.
34. Zarrindast M.R., Nasehi M., Piri M., Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55 212-2 injected into the dorsal hippocampus in mice. Pharmacol. Biochem. Behav. 2010, 94:387-396.